For decades, mitochondria were understood primarily as the cell’s powerhouses — organelles tasked with converting nutrients into ATP, the universal energy currency of biological systems. That framing, while not wrong, turns out to be dramatically incomplete. A growing body of research now positions mitochondria as sophisticated signalling hubs, capable of communicating directly with the nucleus and influencing gene expression across the entire cell. At the centre of this paradigm shift sits a small but remarkable molecule: MOTS-c.
MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome — specifically within the 12S rRNA gene. Since its discovery in 2015, it has become one of the most actively studied mitochondria-derived peptides (MDPs) in the field, drawing attention from researchers investigating metabolic regulation, exercise physiology, ageing, and cellular stress responses. For those working in peptide research, MOTS-c represents a genuinely novel class of bioactive molecule with wide-ranging implications.
The Discovery: A New Chapter in Mitochondrial Biology
MOTS-c was first identified and characterised by Changhan David Lee and colleagues at the University of Southern California (USC) in a landmark 2015 paper published in Cell Metabolism. The discovery was part of a broader effort by Lee’s laboratory to explore whether mitochondrial DNA — long thought to encode only 13 proteins, 22 transfer RNAs, and 2 ribosomal RNAs — might harbour additional functional sequences that had been overlooked.
That intuition proved correct. The Lee lab demonstrated that the 12S rRNA gene region of mitochondrial DNA contains a short open reading frame encoding MOTS-c, a peptide that, despite its small size, exhibited significant biological activity in preclinical models. MOTS-c was not the first MDP to be discovered — humanin, identified in 2001, holds that distinction — but it rapidly became one of the most compelling, owing to its apparent involvement in metabolic regulation and its potential relevance to ageing research.
The discovery of MOTS-c helped establish a broader principle: that the mitochondrial genome is more informationally rich than previously appreciated, and that small peptides encoded within it can act as potent signalling molecules.
Why Mitochondria-Derived Peptides Matter
To appreciate why MOTS-c has generated such research interest, it helps to understand the concept of retrograde signalling. Classical molecular biology emphasised communication from the nucleus to the mitochondria — the nucleus sends instructions, the mitochondria follow them. Retrograde signalling describes the reverse: mitochondria sending signals back to the nucleus, influencing nuclear gene expression and broader cellular behaviour.
This is a profound concept. It means mitochondria are not passive energy generators but active participants in cellular decision-making. MDPs like MOTS-c, humanin, and SHLP1-6 (Small Humanin-Like Peptides) appear to be key mediators of this retrograde communication. They are encoded by mitochondrial DNA, translated into functional peptides, and then exert effects that extend well beyond the mitochondrion itself — including, in the case of MOTS-c, translocation to the nucleus under stress conditions.
For researchers, this reframes mitochondrial biology entirely. Understanding how MDPs function, how their expression is regulated, and how they interact with nuclear signalling pathways could shed light on a wide range of biological processes, from metabolic disease to neurodegeneration to the fundamental mechanisms of ageing.
Key Research Areas
AMPK Activation and Metabolic Homeostasis
One of the earliest and most consistent findings in MOTS-c research is its relationship with AMPK (AMP-activated protein kinase), often described as the cell’s master energy sensor. AMPK is activated when cellular energy levels are low, triggering a cascade of responses that promote energy production and inhibit energy-consuming processes.
In the original 2015 study, Lee et al. demonstrated that MOTS-c activates the AMPK pathway, leading to increased glucose uptake and improved metabolic regulation in cell-based (in vitro) models. The peptide appeared to influence the folate-methionine cycle, altering one-carbon metabolism and leading to accumulation of the intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a well-known AMPK activator.
This mechanistic pathway is particularly interesting because it suggests MOTS-c does not activate AMPK directly, but rather modulates upstream metabolic processes that result in AMPK activation. For researchers studying metabolic signalling, this indirect mechanism raises important questions about how mitochondrial peptides interface with broader cellular metabolic networks.
Exercise Mimetic Properties
Perhaps the most eye-catching area of MOTS-c research involves its apparent exercise-mimetic properties. In murine (mouse) models, administration of MOTS-c has been shown to reproduce some of the metabolic effects typically associated with physical exercise — effects that have made it a subject of considerable interest in exercise physiology research.
A notable 2016 study from the Lee laboratory demonstrated that MOTS-c administration in aged mouse models improved physical capacity and exercise performance. The treated mice showed enhanced running endurance and improved metabolic markers compared to controls. These findings were striking because they suggested a mitochondria-derived peptide could partially replicate the systemic metabolic benefits of exercise in animal models — a concept with significant implications for understanding the molecular basis of exercise adaptation.
It is important to emphasise that these findings are from animal models, and the mechanisms by which MOTS-c produces exercise-like effects are still being investigated. However, the consistency of the metabolic improvements observed across multiple studies has kept this research area active and well-funded.
Insulin Sensitivity and Glucose Regulation
Closely related to its metabolic effects, MOTS-c has shown notable activity in preclinical models of glucose regulation. In diet-induced obese (DIO) mouse models — animals fed high-fat diets to produce metabolic dysfunction — MOTS-c administration was associated with improved insulin sensitivity and prevention of diet-induced insulin resistance.
Lee et al. (2015) reported that mice treated with MOTS-c showed significantly improved glucose tolerance compared to untreated controls, even when maintained on a high-fat diet. The peptide appeared to enhance skeletal muscle glucose uptake and reduce hepatic glucose production, suggesting effects across multiple tissue types.
Subsequent studies have reinforced these findings. Research has shown that circulating MOTS-c levels in mouse models correlate with metabolic health markers, and that declining MOTS-c levels are associated with the development of metabolic dysfunction. These observations have positioned MOTS-c as a molecule of interest for researchers studying the molecular underpinnings of metabolic syndrome and related conditions in animal models.
Stress Response and Nuclear Translocation
One of the more remarkable findings in MOTS-c research emerged from studies examining how the peptide responds to cellular stress. In a 2018 study published in Cell Metabolism, the Lee lab demonstrated that under conditions of metabolic stress, MOTS-c translocates from the cytoplasm to the nucleus, where it interacts with nuclear DNA and regulates gene expression.
This is an extraordinary observation. A peptide encoded by mitochondrial DNA, upon sensing stress, physically relocates to the nucleus and modulates the expression of genes involved in antioxidant defence and metabolic adaptation. Specifically, the researchers found that nuclear MOTS-c promotes the expression of genes with antioxidant response elements (AREs), mediated in part through interaction with the transcription factor NRF2 (nuclear factor erythroid 2-related factor 2).
This nuclear translocation mechanism provides a direct molecular link between mitochondrial signalling and nuclear gene regulation — a concrete example of retrograde signalling in action. For researchers, it opens up new avenues of investigation into how cells coordinate mitochondrial and nuclear responses to stress, and how this coordination might deteriorate with age or disease.
MOTS-c, Ageing, and Declining Mitochondrial Function
The connection between MOTS-c and ageing research is perhaps the most conceptually significant dimension of current work on this peptide. Mitochondrial dysfunction is one of the established hallmarks of ageing, and declining mitochondrial function is observed across virtually all model organisms as they age. If mitochondria produce signalling peptides that help maintain metabolic homeostasis, and if the production of those peptides declines with age, then the loss of MDP signalling could be a contributing factor to age-related metabolic decline.
Several lines of evidence support this hypothesis. Studies have shown that circulating MOTS-c levels decline with age in mouse models, and this decline correlates with the onset of age-related metabolic dysfunction. Conversely, administration of MOTS-c in aged mouse models has been associated with improved metabolic function and physical performance, as discussed above.
Research has also explored MOTS-c levels in the context of mitochondrial DNA variations. Because MOTS-c is encoded by mitochondrial DNA, variations in the mitochondrial genome (haplogroups) can produce different MOTS-c variants. Some population-level studies have observed associations between specific mitochondrial haplogroups — and by extension, specific MOTS-c variants — and longevity, although this epidemiological work is correlational and requires careful interpretation.
The broader implication is that MOTS-c may sit at the intersection of two major areas of ageing research: mitochondrial decline and metabolic dysfunction. Understanding how MOTS-c expression is regulated, how it changes over the lifespan, and whether its decline is a cause or consequence of ageing are all active areas of investigation.
Current State of Research and Future Directions
As of 2026, MOTS-c research remains firmly in the preclinical stage. The vast majority of published work has been conducted in cell culture (in vitro) and mouse models (in vivo), and no approved therapeutic applications exist. However, the pace and breadth of research activity have accelerated considerably since the peptide’s discovery.
Key open questions in the field include:
Mechanism of action clarity. While the AMPK-activating effects of MOTS-c are well-documented, the full scope of its signalling interactions remains to be mapped. How does MOTS-c interact with other metabolic pathways? Are there receptor-mediated effects, or does it act primarily through intracellular metabolic modulation?
Tissue-specific effects. Most research has focused on skeletal muscle and liver, but MOTS-c’s effects on other tissues — including adipose tissue, brain, and cardiovascular system — are areas of growing interest.
Regulation of expression. What controls how much MOTS-c mitochondria produce, and why does this decline with age? Is it linked to mitochondrial DNA copy number, transcriptional regulation, or post-transcriptional processing?
Interactions with other MDPs. MOTS-c is one member of a growing family of mitochondria-derived peptides. How do these peptides interact with one another? Are there synergistic or antagonistic relationships between them?
Translational relevance. While animal model data are encouraging, significant work remains to characterise MOTS-c’s pharmacokinetics, stability, and dose-response relationships in ways that could inform future research directions.
The field is also increasingly interested in MOTS-c’s role in the broader context of mitochondrial communication. The discovery that mitochondrial DNA encodes functional signalling peptides has challenged long-held assumptions about mitochondrial biology, and researchers continue to explore whether additional MDPs remain to be discovered.
Handling and Storage Notes for Researchers
For laboratories working with MOTS-c in research settings, proper handling and storage are essential to maintaining peptide integrity and experimental reproducibility.
Storage temperature. Lyophilised MOTS-c should be stored at -20 degrees C or below. For long-term storage, -80 degrees C is recommended.
Reconstitution. The peptide is typically reconstituted in sterile water or an appropriate buffer. Avoid repeated freeze-thaw cycles, which can degrade peptide structure.
Aliquoting. Upon reconstitution, aliquot into single-use volumes to minimise freeze-thaw exposure.
Light and moisture. Store away from direct light and moisture to prevent degradation.
Purity verification. Confirm peptide purity and identity via HPLC and mass spectrometry prior to use in experiments.
Always consult the certificate of analysis provided with your specific lot for detailed quality control data.
Conclusion
MOTS-c represents a genuinely novel class of signalling molecule — a mitochondria-derived peptide that bridges organellar and nuclear communication, influences metabolic regulation at multiple levels, and appears to decline with age in ways that may be biologically significant. Since its discovery by the Lee laboratory at USC in 2015, it has become a focal point for research spanning metabolism, exercise physiology, ageing, and cellular stress responses.
For researchers, MOTS-c offers a window into a previously hidden layer of mitochondrial biology. The questions it raises — about retrograde signalling, about the informational capacity of mitochondrial DNA, about the molecular mechanisms linking mitochondrial function to systemic metabolic health — are among the most exciting in contemporary cell biology.
At Trusted Peptides, we are committed to supporting the research community with high-purity, rigorously tested peptides for laboratory investigation. Our MOTS-c is manufactured to exacting standards and supplied with full analytical documentation, enabling researchers to pursue their work with confidence in the quality of their materials.
This product is intended for research use only. Not for human consumption or diagnostic use.
References and Further Reading
Lee, C., Zeng, J., Drew, B.G., et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443-454.
Lee, C., Kim, K.H., Cohen, P. (2016). MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radical Biology and Medicine, 100, 182-187.
Kim, K.H., Son, J.M., Benayoun, B.A., Lee, C. (2018). The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism, 28(3), 516-524.
Reynolds, J.C., Lai, R.W., Woodhead, J.S.T., et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12, 470.
Published by Trusted Peptides. For research use only.
MOTS-c: The Mitochondrial Peptide at the Frontier of Ageing Research
For decades, mitochondria were understood primarily as the cell’s powerhouses — organelles tasked with converting nutrients into ATP, the universal energy currency of biological systems. That framing, while not wrong, turns out to be dramatically incomplete. A growing body of research now positions mitochondria as sophisticated signalling hubs, capable of communicating directly with the nucleus and influencing gene expression across the entire cell. At the centre of this paradigm shift sits a small but remarkable molecule: MOTS-c.
MOTS-c (Mitochondrial Open reading frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded within the mitochondrial genome — specifically within the 12S rRNA gene. Since its discovery in 2015, it has become one of the most actively studied mitochondria-derived peptides (MDPs) in the field, drawing attention from researchers investigating metabolic regulation, exercise physiology, ageing, and cellular stress responses. For those working in peptide research, MOTS-c represents a genuinely novel class of bioactive molecule with wide-ranging implications.
The Discovery: A New Chapter in Mitochondrial Biology
MOTS-c was first identified and characterised by Changhan David Lee and colleagues at the University of Southern California (USC) in a landmark 2015 paper published in Cell Metabolism. The discovery was part of a broader effort by Lee’s laboratory to explore whether mitochondrial DNA — long thought to encode only 13 proteins, 22 transfer RNAs, and 2 ribosomal RNAs — might harbour additional functional sequences that had been overlooked.
That intuition proved correct. The Lee lab demonstrated that the 12S rRNA gene region of mitochondrial DNA contains a short open reading frame encoding MOTS-c, a peptide that, despite its small size, exhibited significant biological activity in preclinical models. MOTS-c was not the first MDP to be discovered — humanin, identified in 2001, holds that distinction — but it rapidly became one of the most compelling, owing to its apparent involvement in metabolic regulation and its potential relevance to ageing research.
The discovery of MOTS-c helped establish a broader principle: that the mitochondrial genome is more informationally rich than previously appreciated, and that small peptides encoded within it can act as potent signalling molecules.
Why Mitochondria-Derived Peptides Matter
To appreciate why MOTS-c has generated such research interest, it helps to understand the concept of retrograde signalling. Classical molecular biology emphasised communication from the nucleus to the mitochondria — the nucleus sends instructions, the mitochondria follow them. Retrograde signalling describes the reverse: mitochondria sending signals back to the nucleus, influencing nuclear gene expression and broader cellular behaviour.
This is a profound concept. It means mitochondria are not passive energy generators but active participants in cellular decision-making. MDPs like MOTS-c, humanin, and SHLP1-6 (Small Humanin-Like Peptides) appear to be key mediators of this retrograde communication. They are encoded by mitochondrial DNA, translated into functional peptides, and then exert effects that extend well beyond the mitochondrion itself — including, in the case of MOTS-c, translocation to the nucleus under stress conditions.
For researchers, this reframes mitochondrial biology entirely. Understanding how MDPs function, how their expression is regulated, and how they interact with nuclear signalling pathways could shed light on a wide range of biological processes, from metabolic disease to neurodegeneration to the fundamental mechanisms of ageing.
Key Research Areas
AMPK Activation and Metabolic Homeostasis
One of the earliest and most consistent findings in MOTS-c research is its relationship with AMPK (AMP-activated protein kinase), often described as the cell’s master energy sensor. AMPK is activated when cellular energy levels are low, triggering a cascade of responses that promote energy production and inhibit energy-consuming processes.
In the original 2015 study, Lee et al. demonstrated that MOTS-c activates the AMPK pathway, leading to increased glucose uptake and improved metabolic regulation in cell-based (in vitro) models. The peptide appeared to influence the folate-methionine cycle, altering one-carbon metabolism and leading to accumulation of the intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a well-known AMPK activator.
This mechanistic pathway is particularly interesting because it suggests MOTS-c does not activate AMPK directly, but rather modulates upstream metabolic processes that result in AMPK activation. For researchers studying metabolic signalling, this indirect mechanism raises important questions about how mitochondrial peptides interface with broader cellular metabolic networks.
Exercise Mimetic Properties
Perhaps the most eye-catching area of MOTS-c research involves its apparent exercise-mimetic properties. In murine (mouse) models, administration of MOTS-c has been shown to reproduce some of the metabolic effects typically associated with physical exercise — effects that have made it a subject of considerable interest in exercise physiology research.
A notable 2016 study from the Lee laboratory demonstrated that MOTS-c administration in aged mouse models improved physical capacity and exercise performance. The treated mice showed enhanced running endurance and improved metabolic markers compared to controls. These findings were striking because they suggested a mitochondria-derived peptide could partially replicate the systemic metabolic benefits of exercise in animal models — a concept with significant implications for understanding the molecular basis of exercise adaptation.
It is important to emphasise that these findings are from animal models, and the mechanisms by which MOTS-c produces exercise-like effects are still being investigated. However, the consistency of the metabolic improvements observed across multiple studies has kept this research area active and well-funded.
Insulin Sensitivity and Glucose Regulation
Closely related to its metabolic effects, MOTS-c has shown notable activity in preclinical models of glucose regulation. In diet-induced obese (DIO) mouse models — animals fed high-fat diets to produce metabolic dysfunction — MOTS-c administration was associated with improved insulin sensitivity and prevention of diet-induced insulin resistance.
Lee et al. (2015) reported that mice treated with MOTS-c showed significantly improved glucose tolerance compared to untreated controls, even when maintained on a high-fat diet. The peptide appeared to enhance skeletal muscle glucose uptake and reduce hepatic glucose production, suggesting effects across multiple tissue types.
Subsequent studies have reinforced these findings. Research has shown that circulating MOTS-c levels in mouse models correlate with metabolic health markers, and that declining MOTS-c levels are associated with the development of metabolic dysfunction. These observations have positioned MOTS-c as a molecule of interest for researchers studying the molecular underpinnings of metabolic syndrome and related conditions in animal models.
Stress Response and Nuclear Translocation
One of the more remarkable findings in MOTS-c research emerged from studies examining how the peptide responds to cellular stress. In a 2018 study published in Cell Metabolism, the Lee lab demonstrated that under conditions of metabolic stress, MOTS-c translocates from the cytoplasm to the nucleus, where it interacts with nuclear DNA and regulates gene expression.
This is an extraordinary observation. A peptide encoded by mitochondrial DNA, upon sensing stress, physically relocates to the nucleus and modulates the expression of genes involved in antioxidant defence and metabolic adaptation. Specifically, the researchers found that nuclear MOTS-c promotes the expression of genes with antioxidant response elements (AREs), mediated in part through interaction with the transcription factor NRF2 (nuclear factor erythroid 2-related factor 2).
This nuclear translocation mechanism provides a direct molecular link between mitochondrial signalling and nuclear gene regulation — a concrete example of retrograde signalling in action. For researchers, it opens up new avenues of investigation into how cells coordinate mitochondrial and nuclear responses to stress, and how this coordination might deteriorate with age or disease.
MOTS-c, Ageing, and Declining Mitochondrial Function
The connection between MOTS-c and ageing research is perhaps the most conceptually significant dimension of current work on this peptide. Mitochondrial dysfunction is one of the established hallmarks of ageing, and declining mitochondrial function is observed across virtually all model organisms as they age. If mitochondria produce signalling peptides that help maintain metabolic homeostasis, and if the production of those peptides declines with age, then the loss of MDP signalling could be a contributing factor to age-related metabolic decline.
Several lines of evidence support this hypothesis. Studies have shown that circulating MOTS-c levels decline with age in mouse models, and this decline correlates with the onset of age-related metabolic dysfunction. Conversely, administration of MOTS-c in aged mouse models has been associated with improved metabolic function and physical performance, as discussed above.
Research has also explored MOTS-c levels in the context of mitochondrial DNA variations. Because MOTS-c is encoded by mitochondrial DNA, variations in the mitochondrial genome (haplogroups) can produce different MOTS-c variants. Some population-level studies have observed associations between specific mitochondrial haplogroups — and by extension, specific MOTS-c variants — and longevity, although this epidemiological work is correlational and requires careful interpretation.
The broader implication is that MOTS-c may sit at the intersection of two major areas of ageing research: mitochondrial decline and metabolic dysfunction. Understanding how MOTS-c expression is regulated, how it changes over the lifespan, and whether its decline is a cause or consequence of ageing are all active areas of investigation.
Current State of Research and Future Directions
As of 2026, MOTS-c research remains firmly in the preclinical stage. The vast majority of published work has been conducted in cell culture (in vitro) and mouse models (in vivo), and no approved therapeutic applications exist. However, the pace and breadth of research activity have accelerated considerably since the peptide’s discovery.
Key open questions in the field include:
The field is also increasingly interested in MOTS-c’s role in the broader context of mitochondrial communication. The discovery that mitochondrial DNA encodes functional signalling peptides has challenged long-held assumptions about mitochondrial biology, and researchers continue to explore whether additional MDPs remain to be discovered.
Handling and Storage Notes for Researchers
For laboratories working with MOTS-c in research settings, proper handling and storage are essential to maintaining peptide integrity and experimental reproducibility.
Always consult the certificate of analysis provided with your specific lot for detailed quality control data.
Conclusion
MOTS-c represents a genuinely novel class of signalling molecule — a mitochondria-derived peptide that bridges organellar and nuclear communication, influences metabolic regulation at multiple levels, and appears to decline with age in ways that may be biologically significant. Since its discovery by the Lee laboratory at USC in 2015, it has become a focal point for research spanning metabolism, exercise physiology, ageing, and cellular stress responses.
For researchers, MOTS-c offers a window into a previously hidden layer of mitochondrial biology. The questions it raises — about retrograde signalling, about the informational capacity of mitochondrial DNA, about the molecular mechanisms linking mitochondrial function to systemic metabolic health — are among the most exciting in contemporary cell biology.
At Trusted Peptides, we are committed to supporting the research community with high-purity, rigorously tested peptides for laboratory investigation. Our MOTS-c is manufactured to exacting standards and supplied with full analytical documentation, enabling researchers to pursue their work with confidence in the quality of their materials.
This product is intended for research use only. Not for human consumption or diagnostic use.
References and Further Reading
Published by Trusted Peptides. For research use only.